{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:18:30Z","timestamp":1787681910771,"version":"build-2784847793"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Lower-income patients with sarcoidosis experience worse outcomes than those with higher incomes. The reasons for these disparities are not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify patient-reported barriers to and facilitators of self-empowered care among patients with sarcoidosis residing in high- and low-median-income zip-code areas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with biopsy-proven sarcoidosis who had received pharmacologic treatment within the past year and who were cared for in a sarcoidosis clinic of a large, urban medical system were included. Focus groups were stratified by high- and low-median-income zip-code areas. Transcriptions were analyzed using grounded theory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five focus groups were created; two included patients living in zip-code areas with high median incomes ($84,263; interquartile range [IQR], $79,334\u2013$89,795), and three included patients living in zip-code areas with low median incomes ($27,470; IQR, $22,412\u201327,597). Patients with sarcoidosis from low-income and high-income zip-code areas reported remarkably similar experiences. Patients reported that sarcoidosis was a burden owing to its disease manifestations and the adverse effects of treatment, which led to a compromised ability to perform their activities of daily living at home or at work. Reported barriers to care included perceived inadequate knowledge about sarcoidosis among providers, communication barriers with providers, and the high cost of treatment. Patients from low-income zip-code areas experienced discrimination related to race and income, which served to compound their mistrust. Patients sought to overcome these barriers through self-empowerment, including independent learning, self-advocacy, medication nonadherence, and use of alternative therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with sarcoidosis who lived in high- and low-income zip-code areas expressed similar overall concerns regarding sarcoidosis care. However, patients from low-income zip-code areas more frequently expressed concerns about racial and income-based discrimination. Patients from both groups addressed these barriers through self-empowerment, which included not adhering to prescribed therapies. Future work should focus on the effects of culturally and socioeconomically congruent, community-engaged interventions for quality of life of patients with sarcoidosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202011-1467oc","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T14:40:26Z","timestamp":1618497626000},"page":"1832-1838","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":34,"title":["Barriers to Care among Patients with Sarcoidosis: A Qualitative Study"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-0251","authenticated-orcid":false,"given":"Logan J.","family":"Harper","sequence":"first","affiliation":[{"name":"Department of Pulmonology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Love","sequence":"additional","affiliation":[{"name":"Mental Health, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijuta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Western Reserve Hospital, Cuyahoga Falls, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-0280","authenticated-orcid":false,"given":"J. Daryl","family":"Thornton","sequence":"additional","affiliation":[{"name":"Center for Reducing Health Disparities and"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"2026012203510668300_bib1","doi-asserted-by":"crossref","first-page":"l5553","DOI":"10.1136\/bmj.l5553","article-title":"New advances in the management of pulmonary sarcoidosis","volume":"367","author":"Culver","year":"2019","journal-title":"BMJ"},{"key":"2026012203510668300_bib2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America: analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203510668300_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"2026012203510668300_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.04.00070503","article-title":"Sarcoidosis: social predictors of severity at presentation","volume":"24","author":"Rabin","year":"2004","journal-title":"Eur Respir J"},{"key":"2026012203510668300_bib5","first-page":"322","article-title":"Pulmonary sarcoidosis: comparison of patients at a university and a municipal hospital","volume":"91","author":"Yeager","year":"1999","journal-title":"J Natl Med Assoc"},{"key":"2026012203510668300_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203510668300_bib7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2105\/AJPH.2018.304883","article-title":"The National Institute on Minority Health and Health Disparities Research Framework","volume":"109","author":"Alvidrez","year":"2019","journal-title":"Am J Public Health"},{"key":"2026012203510668300_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archsurg.2011.2220","article-title":"The association of community health indicators with outcomes for kidney transplant recipients in the United States","volume":"147","author":"Schold","year":"2012","journal-title":"Arch Surg"},{"key":"2026012203510668300_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/MLR.0000000000001214","article-title":"Association between geographic measures of socioeconomic status and deprivation and major surgical outcomes","volume":"57","author":"Crawford","year":"2019","journal-title":"Med Care"},{"key":"2026012203510668300_bib10","doi-asserted-by":"crossref","first-page":"e001057","DOI":"10.1161\/JAHA.114.001057","article-title":"Outcomes and resource utilization in ST\u2013elevation myocardial infarction in the United States: evidence for socioeconomic disparities","volume":"3","author":"Agarwal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026012203510668300_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.publhealth.19.1.173","article-title":"Review of community-based research: assessing partnership approaches to improve public health","volume":"19","author":"Israel","year":"1998","journal-title":"Annu Rev Public Health"},{"key":"2026012203510668300_bib12","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203510668300_bib13","author":"U.S. Census Bureau","year":"2020"},{"key":"2026012203510668300_bib14","volume-title":"The discovery of grounded theory.","author":"Glaser","year":"1967"},{"key":"2026012203510668300_bib15","doi-asserted-by":"publisher","DOI":"10.4135\/9781452230153","volume-title":"Basics of qualitative research: techniques and procedures for developing grounded theory","author":"Corbin","year":"2008","edition":"3rd ed"},{"key":"2026012203510668300_bib16","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.rmed.2018.09.016","article-title":"Work ability before and after sarcoidosis diagnosis in Sweden","volume":"144S","author":"Arkema","year":"2018","journal-title":"Respir Med"},{"key":"2026012203510668300_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","article-title":"Association of medication adherence and clinical outcomes in sarcoidosis","volume":"158","author":"Sharp","year":"2020","journal-title":"Chest"},{"key":"2026012203510668300_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1037\/hea0000368","author":"Cuevas","year":"2016","journal-title":"Health Psychol"},{"key":"2026012203510668300_bib19","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.amepre.2016.09.024","article-title":"Perceived discrimination and privilege in health care: the role of socioeconomic status and race","volume":"52","author":"Stepanikova","year":"2017","journal-title":"Am J Prev Med"},{"key":"2026012203510668300_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.pec.2016.11.022","article-title":"How does patient\u2013provider communication influence adherence to asthma medications?","volume":"100","author":"Young","year":"2017","journal-title":"Patient Educ Couns"},{"key":"2026012203510668300_bib21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1513\/AnnalsATS.201702-167WS","article-title":"An American Thoracic Society\/National Heart, Lung, and Blood Institute Workshop Report: addressing respiratory health equality in the United States","volume":"14","author":"Celed\u00f3n","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203510668300_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3109\/02770903.2013.812655","article-title":"Feasibility, acceptability and preliminary effectiveness of patient advocates for improving asthma outcomes in adults","volume":"50","author":"Apter","year":"2013","journal-title":"J Asthma"},{"key":"2026012203510668300_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.ajkd.2005.03.018","article-title":"Peer mentoring: a culturally sensitive approach to end-of-life planning for long-term dialysis patients","volume":"46","author":"Perry","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2026012203510668300_bib24","first-page":"5","article-title":"Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study","volume":"88","author":"Magnani","year":"2017","journal-title":"Acta Biomed"},{"key":"2026012203510668300_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"key":"2026012203510668300_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2026012203510668300_bib27","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1136\/bmjqs-2013-002363","article-title":"Improving chronic care delivery and outcomes: the impact of the Cystic Fibrosis Care Center Network","volume":"23","author":"Mogayzel","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"2026012203510668300_bib28","author":"Pulmonary Fibrosis Foundation","year":"2020"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/11\/1832\/66337100\/annalsats_18_11_1832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/11\/1832\/66337100\/annalsats_18_11_1832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:57:00Z","timestamp":1769072220000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/18\/11\/1832\/8419196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202011-1467oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"2020-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}